Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 25, 2023
Event: Entry into a Material Definitive Agreement for a Registered Direct Offering of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than periodic operating results. Key financial figures related to the transaction include:
- Shares Sold: 3,000,000 shares of common stock.
- Offering Price: $5.50 per share.
- Gross Proceeds: Approximately $16.5 million.
- Placement Agent Fees: 6.0% of gross proceeds plus expense reimbursement up to $75,000.
- Estimated Net Proceeds: Approximately $15.2 million.
Note: The filing does not provide current revenue, profit, cash flow, margins, or debt levels. These metrics are not applicable to this specific transaction report.
Material Changes
The primary material change is the increase in equity capital and cash liquidity resulting from the sale of 3,000,000 shares. This transaction represents a dilution of existing shareholders but provides immediate liquidity to the company.
Guidance, Outlook, and Use of Proceeds
Use of Proceeds: Management intends to use the net proceeds to fund:
- Product development.
- Regulatory activities.
- Working capital and general corporate purposes.
Risks and Contingencies: The filing includes standard forward-looking statements cautioning that actual results may differ materially from expectations due to risks identified in the Company's Form 10-Q for the period ended March 31, 2023, and the prospectus supplement. The Company disclaims any obligation to update these statements.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received after all expenses.
- Review the full Securities Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions.
- Check the Company's most recent Form 10-Q (filed May 9, 2023) for current cash burn rates and existing debt obligations.
- Confirm the impact of the 3,000,000 new shares on total outstanding share count and earnings per share.